Morphosys AG - ADR Stock, NASDAQ:MOR
Semmelweisstrasse 7, Semmelweisstrasse 7, Planegg, Bayern (Bavaria) 82152
Number of Employees: 732
MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.